Publications by authors named "Bergquist Filip"

Claim this Profile
H
Health-Related Quality of Life in Relation to the 5-2-1 Criteria in Parkinson's Disease in Sweden.
Frida Hjalte, Anna Gustafsson, Jenny Samuelsson, Filip Bergquist, Anders Johansson

Mov Disord Clin Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dopamine stabilizer (-)-OSU6162 attenuates levodopa-induced dyskinesia in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Daniela Atanasovski, Filip Bergquist, Elias Eriksson, Thomas Carlsson

Neuroscience· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017).
Mats Dehlin, Filip Bergquist, Panagiota Drivelegka, Tatiana Zverkowa Sandström, Lennart T H Jacobsson

Rheumatol Adv Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous subcutaneous infusion therapies in Parkinson's disease: evidence of efficacy and safety.
Regina Katzenschlager, Filip Bergquist

Parkinsonism Relat Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.
Per Svenningsson, Per Odin, Filip Bergquist, Karin Wirdefeldt, Dag Nyholm

Mov Disord· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"How to save a marriage": treatment of REM sleep behavior disorder (RBD) with acetyl-leucine in a patient with Parkinson's disease.
Wolfgang H Oertel, Martin T Henrich, Filip Bergquist, Annette Janzen, Fanni F Geibl

J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rotigotine on sleep in Parkinson's disease patients: a Parkinson's KinetiGraph study.
Sotirios Grigoriou, Carin Janz, Malcolm Horne, Filip Bergquist, Nil Dizdar

Front Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease.
Mezin Öthman, Filip Bergquist, Per Odin, Monica Scharfenort, Anders Johansson

Eur J Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Online quizzes for practice and assessment of pharmacotherapeutic knowledge during clinical courses in medical school - a pilot study in the psychiatry and neurology courses].
Susanna M Wallerstedt, Katarina Jood, Silke Kern, Catrin Rönnbäck, Steinn Steingrimsson, Filip Bergquist

Lakartidningen· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion.
Filip Bergquist, Mats Ehrnebo, Dag Nyholm, Anders Johansson, Fredrik Lundin

Mov Disord Clin Pract· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa.
K Ray Chaudhuri, Maurizio F Facheris, Bruno Bergmans, Filip Bergquist, Susan R Criswell

Mov Disord Clin Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.
Victor S C Fung, Jason Aldred, Martha P Arroyo, Filip Bergquist, Agnita J W Boon

Clin Park Relat Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist

Neurol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist

Neurol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Swedish Patient-Reported Outcomes in Parkinson's Disease Scale in Outpatients.
Daniel von Below, Susanna M Wallerstedt, Filip Bergquist

Mov Disord· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.
Filip Bergquist, Mats Ehrnebo, Dag Nyholm, Anders Johansson, Fredrik Lundin

Neurology· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Treatment of Parkinson's Disease.
Dag Nyholm, Filip Bergquist

J Pers Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Ambulatory Objective Movement Measurement for Outcomes of Levodopa/Carbidopa Intestinal Gel Infusion.
Gökçe Kilinçalp, Anne-Christine Sjöström, Barbro Eriksson, Björn Holmberg, Radu Constantinescu, Filip Bergquist

J Pers Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of glucagon-like peptide-1 receptors and skilled reach foraging.
Jesper Vestlund, Filip Bergquist, Valentina Licheri, Louise Adermark, Elisabet Jerlhag

Addict Biol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life with Parkinson's Disease During the COVID-19 Pandemic: The Pressure Is "OFF".
Trine HØrmann Thomsen, Susanna M Wallerstedt, Kristian Winge, Filip Bergquist

J Parkinsons Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease.
Peter Hagell, Arja Höglund, Carina Hellqvist, Eva-Lena Johansson, Berit Löwed, Filip Bergquist

J Neurol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multiple motion sensors index for motor state quantification in Parkinson's disease.
Somayeh Aghanavesi, Jerker Westin, Filip Bergquist, Dag Nyholm, Håkan Askmark

Comput Methods Programs Biomed· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.
Per Svenningsson, Per Odin, Nil Dizdar, Anders Johansson, Sotirios Grigoriou, Filip Bergquist

Mov Disord· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective measurement in Parkinson's disease: a descriptive analysis of Parkinson's symptom scores from a large population of patients across the world using the Personal KinetiGraph®.
Rajesh Pahwa, Filip Bergquist, Malcolm Horne, Michael E Minshall

J Clin Mov Disord· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Parkinson's disease - heterogeneous and complex in its clinical presentation].
Filip Bergquist, Anders Johansson, Nil Dizdar, Håkan Widner, Dag Nyholm

Lakartidningen· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis